Shree Ganesh Remedies Ltd reported a 3% decrease in revenue to ₹32.33 crore for Q2 FY25, with a PAT of ₹6.39 crore, highlighting strong profitability and growth despite challenges in the European market. For H1 FY25, the revenue was ₹57.11 crore, a 5% decrease YoY, with an EBITDA margin of 34.03%.